Related Experiment Video
Updated: Aug 17, 2026

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
Published on: January 9, 2026
Gastrointestinal symptoms as an important sign in premature newborns with severely increased S-digoxin
1Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, DK-5000 Odense, Denmark. mads.nybo@ouh.fyns-amt.dk
Insights
Digoxin intoxication in newborns often presents with extracardiac symptoms, not cardiac ones. Alertness to gastrointestinal signs and monitoring potassium levels are crucial for early detection in infants.
Area of Science:
- Neonatal pharmacology
- Pediatric toxicology
Background:
- Digoxin is commonly prescribed for neonatal heart conditions.
- Adults typically exhibit cardiac symptoms during digoxin intoxication.
- Infants, especially preterm neonates, display altered digoxin sensitivity and tissue distribution.
Observation:
- A case of severe digoxin intoxication in a preterm infant is presented.
- The infant exhibited significant gastrointestinal symptoms with minimal cardiac effects.
- Altered symptomatology in neonates can delay diagnosis of digoxin overdose.
Findings:
- Extracardiac symptoms, particularly gastrointestinal, are critical indicators of digoxin intoxication in newborns.
- Elevated serum potassium (P-Potassium) can predict digoxin toxicity.
- Therapeutic drug monitoring is essential when digoxin overdose is suspected in neonates.
Implications:
- Increased clinical awareness of non-cardiac digoxin toxicity signs in neonates is vital.
- Early detection through monitoring extracardiac symptoms and potassium levels can prevent severe outcomes.
- Standardized therapeutic drug monitoring protocols are needed for neonatal digoxin use.
Abstract:
The aim is to emphasize the importance of extracardiac symptoms of digoxin intoxication in newborns. The most common intoxication symptoms in adults are of cardiac origin, but due to altered symptomatology, digoxin overdose in infants are not always discovered on symptomatic basis. In preterm infants, this is even more pronounced due to diminished digoxin sensitivity. Also, tissue distribution is altered in newborns, which, combined with the need for higher doses in newborns to obtain clinical effect, underscores the need for the utmost care, when newborns receive digoxin treatment to avoid intoxication. We report a case of severe digoxin intoxication in a preterm newborn infant, leading to distinct gastrointestinal symptoms, but only minor cardiac affection. The literature concerning digoxin intoxication and digoxin measurement is reviewed to elucidate the case report. In conclusion, alertness should be drawn to extracardiac symptoms of digoxin intoxication, especially in newborns, and P-Potassium can serve as a predictor and thereby strengthen any given suspicion. Therapeutic drug monitoring should be performed, as soon as digoxin overdose due to the above-mentioned signs is suspected in spite of vague cardiac symptoms.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy